Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Februar 2026 09:05 ET | Quelle: Wearable Devices Ltd.

Wearable Devices Launches ai6 Labs: The Ecosystem Bridging Intent to Digital Reality

ai6 Labs: a synergistic neural AI ecosystem driving the future through integrated research, product monetization, and accelerated AI breakthroughs Yokneam Illit, Israel, Feb. 11, 2026 (GLOBE...
11. Februar 2026 06:00 ET | Quelle: Lixiang Education Holding Co., Ltd.

Lixiang Education Received Notice of Failure to Satisfy Continued Listing Rule

LISHUI, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (the “Company” or NASDAQ: LXEH), a prestigious private education service provider in China, today announced that...
10. Februar 2026 08:00 ET | Quelle: EQV Ventures Acquisition Corp.

Presidio Announces Proposed $1 Billion Acquisition Financing Facility with Goldman Sachs

Acquisition Facility expected to accelerate asset acquisition strategy Fort Worth, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Presidio Investment Holdings LLC (“Presidio” or the “Company”), a...
05. Februar 2026 07:15 ET | Quelle: Jiuzi Holdings Inc.

Multiple Crypto Strategic Investment Institutions Commit US$40 Million in Assets to Jiuzi Holdings at a Price Not Lower Than US$1.50 per Share, with the Transaction to Be Completed Within Two Weeks

HANGZHOU, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) (the “Company”) today announced that it has entered into strategic arrangements with several Crypto-focused...
05. Februar 2026 07:00 ET | Quelle: Can-Fite BioPharma Ltd.

Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson

Namodenoson Provided Clinical Stabilization as a Potential Bridge to Transplant in Advanced Liver Failure Ramat Gan, Israel, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE...
04. Februar 2026 08:30 ET | Quelle: Golden Sun Technology Group Limited

Golden Sun Technology Group Limited Announces Corporate Name Change

Shanghai, China, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Golden Sun Technology Group Limited (the “Company” or “Golden Sun”), announced today that it has changed its corporate name from “Golden Sun...
27. Januar 2026 08:40 ET | Quelle: Maris-Tech Ltd.

Maris-Tech Receives Follow-On Purchase Order for Intelligence Gathering Application

The success of the development phase moves the technology to operational product deployment Rehovot, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech”...
16. Dezember 2025 08:45 ET | Quelle: Clearmind Medicine Inc.

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and...
12. Dezember 2025 08:32 ET | Quelle: Clearmind Medicine Inc.

Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment

Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...
12. Dezember 2025 06:32 ET | Quelle: Clearmind Medicine Inc.

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...

Nächste Seite